Biocon launches biosimilars - Bosaya and Aukelso in U.S.
Mumbai, April 7 -- Biocon announced the commercial launch of Bosaya™ (denosumab-kyqq) and Aukelso™ (denosumab kyqq) in the United States.
Published by HT Digital Content Services with permission from Capital Market....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.
